Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.
about
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningUse of carbon monoxide in minimizing ischemia/reperfusion injury in transplantationReview article: carbon monoxide in gastrointestinal physiology and its potential in therapeuticsInhaled carbon monoxide provides cerebral cytoprotection in pigsDivergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia.MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice.Targeting heme oxygenase-1 in vascular diseaseExogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning.Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injuryExogenous carbon monoxide attenuates inflammatory responses in the small intestine of septic mice.Role of carbon monoxide in cardiovascular function.Carbon monoxide stimulates Ca2+ -dependent big-conductance K channels in the cortical collecting duct.CO-releasing molecules (CORM-2)-liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice.CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.Cerebroprotective functions of HO-2.Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanismENDOGENOUS CARBON MONOXIDE CONCENTRATION IN BLOOD ELEVATES IN ACUTE CORONARY SYNDROME OF NONSMOKER POPULATION.Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice.Carbon monoxide: an unusual drug.Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology.Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules.Heme Oxygenases in Cardiovascular Health and Disease.Mechanism(s) Involved in Carbon Monoxide-releasing Molecule-2-mediated Cardioprotection During Ischaemia-reperfusion Injury in Isolated Rat Heart.Heme oxygenase system in hepatic ischemia-reperfusion injuryCarbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2.Synthesis and Characterization of a "Turn-On" photoCORM for Trackable CO Delivery to Biological Targets.Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia/reperfusion injury in diabetic and normal mice.Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury.
P2860
Q26825733-9FA19744-5F85-4A02-9627-A899B83746ECQ26850661-F4D0FD48-DBE4-48B1-A1E6-36A900499A3FQ27025929-4FB44075-16EB-41F3-AB60-D2A40A80B0E5Q31081214-A4B05ADD-B0D3-496B-8FB1-0368E53DC610Q33471430-E2F32AE0-56F0-45C6-8837-00FD51E6A048Q33794323-8F07C18D-BFE8-4C5C-8D21-DB966CF78D3AQ34299531-131A5A12-D62C-4736-A73D-14E3C7975DC9Q34664601-35EAF508-E721-46D8-9AD3-01AC3A54A842Q34995661-2D33BA8D-FE2C-4439-A6F7-0BBEF8FBCF66Q36109838-07A57540-3C2E-4D26-8202-5AB8BA95D131Q36259597-453759A5-8712-4FD4-94C0-F38F61D4CF9BQ36357446-09BA7BF8-7385-4383-8C38-F285EE8143F9Q36600436-4E62A749-A889-4671-9454-D436B073E7DEQ36699843-0CAED05B-2FED-4490-B2DA-2FE2CE2729E0Q36727192-E78A7294-070F-43F9-9FEF-0B10614E9C06Q36842525-8B814119-A5A0-496C-91AF-D31A63FDE097Q36921100-667A8CCC-9F89-4D0F-9075-4D0DE19F4F58Q37090266-7AC256B4-80CC-4EBE-820E-E995DAFADBD3Q37138975-4D4306E2-38B4-441A-8FED-42B21887299EQ37461039-86DF5663-014D-4C16-A3E2-5361F9FF2061Q37660699-9DE3D690-517D-4B96-864E-BE662DB325A3Q37995139-45090643-7540-4882-9E25-227F60010392Q38262595-0445B62B-9CB5-454E-81CE-5CDD4857FF19Q38698568-FC4D4FC0-61B7-41E0-8DDA-762550A7ED21Q38823562-D008E856-F7E0-4589-A54F-77E8D8BDF31EQ39955500-2E82ECD7-ED97-40C5-9FB0-B9EB84CA3E11Q41544727-669F68A5-D952-4665-B058-9B4146C5BD7FQ41863680-B8B02E9C-BC3F-401B-A249-3067185298DCQ42617749-522065E9-8739-4504-960D-7C86D9B4E898Q44014025-53484130-377E-47A2-87D8-1604F5786DD6Q48105172-C98BDB1D-F405-4442-B5E1-0988EB1E1D98
P2860
Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Administration of a CO-releasi ...... against myocardial infarction.
@ast
Administration of a CO-releasi ...... against myocardial infarction.
@en
type
label
Administration of a CO-releasi ...... against myocardial infarction.
@ast
Administration of a CO-releasi ...... against myocardial infarction.
@en
prefLabel
Administration of a CO-releasi ...... against myocardial infarction.
@ast
Administration of a CO-releasi ...... against myocardial infarction.
@en
P2093
P2860
P1476
Administration of a CO-releasi ...... against myocardial infarction.
@en
P2093
Adam B Stein
Buddhadeb Dawn
Qianhong Li
Roberto Bolli
Tony R Johnson
Wen-Jian Wu
Xiaoping Zhu
P2860
P304
P356
10.1016/J.YJMCC.2004.10.006
P577
2004-12-08T00:00:00Z